Structural and Dynamics Perspectives on the Binding of Substrate and Inhibitors in Mycobacterium tuberculosis DHFR

Dihydrofolate reductase (DHFR), an essential enzyme in the folate pathway, is a potential target for new anti-tuberculosis drugs. Fifteen crystal structures of Mycobacterium tuberculosis DHFR complexed with NADPH and various inhibitors are available in the RCSB Protein Data Bank, but none of them is...

Descripción completa

Detalles Bibliográficos
Autores principales: Sittikornpaiboon, Pimonluck, Toochinda, Pisanu, Lawtrakul, Luckhana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620518/
https://www.ncbi.nlm.nih.gov/pubmed/28914808
http://dx.doi.org/10.3390/scipharm85030031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620518/
https://www.ncbi.nlm.nih.gov/pubmed/28914808
http://dx.doi.org/10.3390/scipharm85030031

Ejemplares similares